Sponsor or institution

Clinical trials and research at CytoCares Inc

As of November 12, 2026, Find a Trial lists 4 clinical trials run by CytoCares Inc that are recruiting, in China. By phase: Phase 1 (2), Early Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
CC312 for relapsed or treatment‑resistant lupus, inflammatory myopathies, and systemic sclerosis Early Phase 1 Deyang, Sichuan Recruiting Sep 26, 2025
CC312 for adults with moderate to severe lupus Phase 1 Chengdu, Sichuan Recruiting Sep 17, 2025
Safety evaluation of CC312 in patients with autoimmune diseases Early Phase 1 Tianjin, China Recruiting Mar 21, 2025
Safety evaluation of CC312 in adults with relapsed B-cell cancers Phase 1 Tianjin, Tianjin Municipality Recruiting Sep 14, 2023

All recruiting trials (4)

Quick answers

How many clinical trials run by CytoCares Inc are recruiting right now?

4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2, Early Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.